ACORDA THERAPEUTICS INC (ACOR)
US00484M7002 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -252.85M | -65.90M | -104.00M | -99.60M | -273.00M | |||
| Depreciation Amortization | 31.67M | 32.80M | 34.00M | 41.30M | 34.60M | |||
| Change In Working Capital | -10.83M | 1.70M | 24.90M | -12.00M | -41.40M | |||
| Interest Paid | 12.42M | 7.20M | 0.00 | 6.70M | 6.10M | |||
| Taxes Paid | 804.00K | 200.00K | 100.00K | 300.00K | 2.80M | |||
| Other non cash items | 218.03M | 10.50M | 3.70M | 9.20M | 151.60M | |||
| OPERATING CASH FLOW | -13.98M | -20.90M | -41.30M | -61.00M | -128.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -264.00K | -100.00K | -200.00K | -4.40M | -90.40M | |||
| Other Investing Activity | N/A | 0.00 | 74.00M | 63.80M | 89.90M | |||
| INVESTING CASH FLOW | -264.00K | -100.00K | 73.80M | 59.40M | -500.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -69.70M | -600.00K | -55.80M | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | N/A | -100.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | -1.10M | -4.70M | |||
| FINANCING CASH FLOW | N/A | 0.00 | -69.70M | -1.70M | -60.60M | |||
| Exchange Rate Effect | 188.00K | 500.00K | -400.00K | 1.00M | 100.00K | |||
| CHANGE IN CASH | -14.06M | -20.50M | -37.60M | -2.30M | -189.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.98M | -20.90M | -41.30M | -61.00M | -128.20M | |||
| Capital Expenditure | -264.00K | -100.00K | -200.00K | -4.40M | -90.40M | |||
| FREE CASH FLOW | -14.25M | -21.00M | -41.50M | -65.40M | -218.60M | |||
All data in USD